Overview

Oral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease Patients on Hemodialysis

Status:
Not yet recruiting

Trial end date:
2024-08-01

Target enrollment:

Participant gender:

Summary

The study will test and compare the efficacy of a single essential amino acid valine with a combination of essential amino acids (EAA) supplement on fatigue, frailty, and cognitive function in end-stage kidney disease (ESKD) patients undergoing hemodialysis (HD) treatment.

Phase:

Early Phase 1

Details

Lead Sponsor:

The University of Texas Health Science Center at San Antonio

Collaborators:

IIMS-UT Health San Antonio
National Center for Advancing Translational Sciences (NCATS)